29. Sep 2022 News Taking a page from the Amazon playbook, Berlin’s cross-selling specialist 35up banks another €5 million
10. Sep 2022 News CatalYm Demonstrates Clinical Efficacy and Tolerability in First-in- Human Phase 1 Trial for Visugromab and Nivolumab Combination
21. Jul 2022 News Cologne-based ONIQ nets €3.5 million to improve carbon footprint of manufactured products
20. Jul 2022 News Cardior Announces First Patient Dosed in Phase 2 Study Evaluating Efficacy and Safety of Non-coding RNA- Based Lead Candidate CDR132L in Heart Failure Patients Post- Myocardial Infarction
3. May 2022 News Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies
